Article
Identification of neoantigens in esophageal adenocarcinoma
2022-05-04
Abstract excerpt
Esophageal adenocarcinoma (EAC) has a relatively poor long-term survival and limited treatment options. Promising targets for immunotherapy are short peptide neoantigens containing tumor mutations, presented to cytotoxic T-cells by human leukocyte antigen molecules (HLA). Despite an association between putative neoantigen abundance and therapeutic response across cancers, immunogenic neoantigens are challenging to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e4c1e058-3fc7-5f7c-bb75-de1a354ec82e
- DOI
- 10.1101/2022.05.04.490567
